PRINTER'S NO. 1225
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE RESOLUTION
No.
213
Session of
2017
INTRODUCED BY MENSCH, GREENLEAF, BROOKS, BREWSTER, MARTIN,
SCAVELLO, DINNIMAN, FARNESE, FONTANA, BARTOLOTTA, SABATINA,
LANGERHOLC, RAFFERTY, KILLION AND BROWNE, OCTOBER 3, 2017
INTRODUCED AND ADOPTED, OCTOBER 3, 2017
A RESOLUTION
Designating October 13, 2017, as "Metastatic Breast Cancer
Awareness Day" in Pennsylvania.
WHEREAS, Thousands of families across Pennsylvania are
affected by metastatic breast cancer; and
WHEREAS, There has been tremendous progress on early
detection and routine diagnosis of breast cancer over the last
30 years; and
WHEREAS, Metastatic breast cancer is a later stage of breast
cancer that occurs when the cancer spreads beyond the breast to
other parts of the body, including the bones, lungs, liver and
brain; and
WHEREAS, Metastatic breast cancer patients continue to face
unique challenges including the emotional and physical demands
of continual treatment; and
WHEREAS, Although there is currently no cure for metastatic
breast cancer, treatment is continued indefinitely with the goal
of extending the best quality of life possible; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
WHEREAS, More than one in eight women in the United States
will be diagnosed with invasive breast cancer in their lifetime;
and
WHEREAS, In Pennsylvania, approximately 11,475 people are
expected to be diagnosed with breast cancer in 2017; and
WHEREAS, In the United States, it is estimated that more than
154,000 women have metastatic breast cancer; and
WHEREAS, In Pennsylvania, approximately 2,000 people are
expected to die from breast cancer, nearly all from the
metastatic stage of the disease; and
WHEREAS, Although Caucasian women have the greatest incidence
of breast cancer, the mortality rate for African-American women
with breast cancer is higher and breast cancer is the leading
cause of cancer-related death in Hispanic women; and
WHEREAS, Breast cancer research should include everything
from screening through treatment and support of those with
metastatic breast cancer; and
WHEREAS, The economic burdens on the patient, family and
health care system are large; and
WHEREAS, While there have been advancements in the treatment
of metastatic breast cancer, many of those advancements have
benefited a small subset of patients; and
WHEREAS, There is more research to be done on metastatic
breast cancer and this Commonwealth continues to support
critical research and advanced treatments for metastatic breast
cancer; therefore be it
RESOLVED, That the Senate designate October 13, 2017, as
"Metastatic Breast Cancer Awareness Day" in Pennsylvania.
20170SR0213PN1225 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28